Novo Medi Sciences Private Limited

Milrinone is a medication indicated for cardiac support in patients with acute heart failure, pulmonary hypertension, or chronic heart failure. It is often used during cardiac surgeries, including coronary artery bypass graft surgery, cardiac transplantation, and other cardiac surgeries requiring cardiac support.

 

We are engaged in offering Novo Terlipressin Injection to our clients. Our range of Products is widely appreciated by our clients.

Novo Adrenaline Bitartrate Injection IP is a medication that contains adrenaline (epinephrine) as its active ingredient. It is typically used in emergency situations to treat severe allergic reactions (anaphylaxis), asthma attacks, or cardiac arrest.

Key Features:

• Active Ingredient: Adrenaline (epinephrine) bitartrate.
• Formulation: Usually presented as a sterile solution for injection.
• Indications:
  • Anaphylactic shock
  • Cardiac arrest
  • Severe asthma exacerbations
• Mechanism of Action: Adrenaline works by stimulating alpha and beta-adrenergic receptors, leading to increased heart rate, improved blood flow, bronchodilation, and reduced swelling.

Administration:

• Administered via intramuscular or intravenous injection, depending on the clinical scenario.
• Dosage may vary based on age, weight, and specific condition being treated.

Precautions:

• Monitor patients for potential side effects, including increased heart rate, hypertension, or anxiety.
• Use with caution in patients with cardiovascular diseases or hyperthyroidism.

Storage:

• Store in a cool, dark place and protect from light.

Novo Dobutamine Injection USP is a sterile, non-pyrogenic solution used primarily for short-term management of patients with heart failure or to support cardiac function in certain clinical settings. It contains dobutamine, a synthetic catecholamine that primarily stimulates beta-1 adrenergic receptors in the heart, leading to increased myocardial contractility and stroke volume.

Key Features:

• Indications: Primarily used in the treatment of heart failure, cardiogenic shock, and during cardiac stress tests.
• Dosage Form: Typically available as a clear, colorless solution for intravenous administration.
• Mechanism of Action: Increases cardiac output by enhancing contractility and reducing systemic vascular resistance.
• Side Effects: May include tachycardia, arrhythmias, and increased blood pressure. Monitoring is essential during administration.
• Contraindications: Known hypersensitivity to dobutamine or its components, idiopathic hypertrophic subaortic stenosis, and certain types of aortic stenosis.

Storage and Handling:

Store in a cool, dry place, protected from light. Follow specific guidelines for reconstitution and administration to ensure patient safety and drug efficacy.

Novo Esmolol Injection IP is a medication primarily used for its rapid-acting beta-blocking properties. It's commonly utilized in critical care settings for the management of various cardiac conditions, such as:

• Supraventricular tachycardia: To help control heart rate.
• Hypertension: For quick reduction of elevated blood pressure, especially in emergencies.
• Tachyarrhythmias: To manage irregular heart rhythms.

Description:

• Active Ingredient: Esmolol hydrochloride.
• Formulation: Typically available as a sterile, injectable solution.
• Administration: Administered intravenously, allowing for rapid onset of action.
• Onset of Action: Effects can be seen within minutes, making it suitable for acute situations.
• Duration of Action: Short half-life, requiring continuous infusion for sustained effects.

Indications:

• Acute management of tachycardia and hypertension.
• Control of heart rate during surgical procedures.

Side Effects:

Common side effects may include:

• Hypotension
• Bradycardia
• Dizziness
• Nausea

Contraindications:

• Severe bradycardia
• Cardiogenic shock
• Certain types of heart block

Precautions:

Use with caution in patients with respiratory conditions or those on other antihypertensive medications. Continuous monitoring of heart rate and blood pressure is recommended during administration.

Novo Dopamine Hydrochloride Injection IP is a medication primarily used for its effects as a potent dopamine agonist. It acts to increase cardiac output and improve blood flow in conditions such as shock or severe heart failure.

Key Features:

• Active Ingredient: Dopamine Hydrochloride
• Formulation: Injectable solution
• Indications: Treatment of conditions requiring increased cardiac output, such as cardiogenic shock, septic shock, and heart failure.
• Mechanism of Action: Dopamine acts on dopaminergic receptors, stimulating cardiac contractility and promoting renal perfusion, depending on the dose administered.
• Dosage and Administration: Typically administered intravenously, with dosages tailored to the patient's condition and response.
• Side Effects: Possible side effects include arrhythmias, hypertension, and vasoconstriction.

Storage:

Store in a cool, dry place away from direct sunlight, and keep out of reach of children.

Precautions:

Monitor cardiovascular status and renal function during treatment, and adjust dosing as needed based on patient response.

Novo Vasopressin Injection IP is a synthetic form of the natural hormone vasopressin, which is primarily used for its antidiuretic properties. It acts on the kidneys to promote water reabsorption, thereby helping to regulate fluid balance in the body.

Indications:

• Treatment of diabetes insipidus (central)
• Management of certain types of gastrointestinal hemorrhage
• Use in cardiac arrest situations as part of advanced cardiac life support (ACLS)

Dosage and Administration:

• Administered via subcutaneous, intramuscular, or intravenous injection.
• Dosage varies based on the indication and patient condition; healthcare providers should follow specific guidelines.

Contraindications:

• Hypersensitivity to vasopressin or any of its components.
• Conditions that can lead to water retention or hyponatremia (e.g., congestive heart failure).

Side Effects:

• Common side effects may include nausea, abdominal cramps, headache, and flushing.
• Severe side effects can include water intoxication, electrolyte imbalances, and cardiovascular issues.

Precautions:

• Monitor fluid intake and output closely.
• Be cautious in patients with cardiovascular disease, renal impairment, or seizure disorders.

Storage:

• Store in a cool, dry place, protected from light, and follow specific storage instructions provided by the manufacturer.

Novo Sterile Noradrenaline Concentrate IP is a pharmaceutical preparation containing noradrenaline (norepinephrine), a potent vasopressor used primarily in critical care settings. It acts on alpha-adrenergic receptors to cause vasoconstriction, leading to increased blood pressure and improved perfusion to vital organs.

Key Features:

• Indications: Used in the management of severe hypotension, especially in cases of septic shock or cardiac arrest.
• Formulation: Typically comes in a sterile concentrate that is diluted before administration.
• Dosage and Administration: Administered intravenously, with dosages adjusted based on the patient's response and clinical condition.
• Side Effects: Common side effects may include hypertension, reflex bradycardia, and peripheral ischemia.

Precautions:

• Monitor blood pressure and heart rate closely during administration.
• Ensure proper dilution to avoid local tissue damage.
• Use with caution in patients with cardiovascular disease.

Storage:

• Store at controlled room temperature, protected from light, and follow specific guidelines for stability and shelf life.

Novo Labetalol Injection IP is a medication used primarily for the management of hypertension, particularly in acute settings such as hypertensive emergencies. Labetalol is a combined alpha and beta-adrenergic blocker, which helps to lower blood pressure by dilating blood vessels and reducing heart rate.

Description:

• Composition: Each vial typically contains Labetalol Hydrochloride equivalent to 5 mg/mL.
• Indications: Used for the treatment of severe hypertension, including during pregnancy, and for managing hypertensive crises.
• Mechanism of Action: Labetalol works by blocking alpha-1 receptors, leading to vasodilation, and beta-1 receptors, reducing heart rate and contractility. This dual action results in a significant decrease in blood pressure.
• Dosage and Administration: Administered via slow intravenous injection or infusion, with dosage tailored to the patient's needs and response.
• Side Effects: Common side effects may include dizziness, fatigue, headache, nausea, and hypotension. Serious side effects can include bradycardia and respiratory distress in some patients.
• Contraindications: Contraindicated in patients with bronchial asthma, severe bradycardia, heart block, or certain types of heart failure.
• Storage: Store in a cool, dry place, away from light.

Novo Nitroglycerin Injection IP is a medication primarily used for the management of angina pectoris (chest pain) and for the treatment of heart failure. It works as a vasodilator, helping to relax and widen blood vessels, which improves blood flow and reduces the workload on the heart.

Composition

• Active Ingredient: Nitroglycerin
• Formulation: Typically available in an injectable form, often in ampules or vials.

Indications

• Treatment of acute angina attacks
• Management of severe hypertension, especially during surgical procedures
• Congestive heart failure treatment

Dosage and Administration

• Administered intravenously under medical supervision.
• Dosage is individualized based on patient response and condition severity.

Side Effects

• Common: Headache, dizziness, hypotension (low blood pressure), tachycardia (rapid heartbeat).
• Serious: Allergic reactions, severe hypotension, or syncope (fainting).

Precautions

• Monitor blood pressure and heart rate regularly.
• Use with caution in patients with pre-existing hypotension, hypovolemia, or recent use of phosphodiesterase inhibitors.

Storage

• Store in a cool, dry place away from light. Follow specific manufacturer guidelines for storage.

Novo Labetalol Hydrochloride Injection IP is a medication primarily used for the management of hypertension, especially in acute settings such as hypertensive emergencies. It belongs to the class of drugs known as beta-blockers, specifically a non-selective beta-blocker with alpha-1 blocking activity.

Key Features:

• Composition: Each vial typically contains labetalol hydrochloride as the active ingredient, along with suitable excipients and solvents for injection.
• Mechanism of Action: Labetalol works by blocking beta-adrenergic receptors (both beta-1 and beta-2) and alpha-1 adrenergic receptors. This dual action results in vasodilation and a decrease in heart rate and cardiac output, leading to lower blood pressure.
• Indications: It is indicated for the treatment of severe hypertension and can be used in various clinical situations, including during surgery or in patients with acute heart failure.
• Administration: Administered intravenously, often in a hospital setting, under the supervision of healthcare professionals. Dosage is typically individualized based on the patient’s condition and response to treatment.
• Side Effects: Possible side effects include dizziness, fatigue, nausea, and bradycardia. Serious side effects may include hypotension and bronchospasm.

Precautions:

• Monitor blood pressure and heart rate during administration.
• Use with caution in patients with a history of asthma or chronic obstructive pulmonary disease (COPD) due to potential bronchoconstriction.
• Not recommended for patients with severe hepatic impairment.

Storage:

• Store in a cool, dry place, away from light and moisture. Always check for expiration dates and proper packaging before use.

Novo Labetalol Injection IP is a medication used primarily to manage hypertension (high blood pressure) and to control blood pressure during surgical procedures. Labetalol is a combined alpha and beta-adrenergic antagonist, which means it works by blocking specific receptors in the body to help lower blood pressure.

Key Points:

• Indications: Used for the treatment of hypertension, particularly in emergencies or during surgery.
• Mechanism of Action: It reduces peripheral vascular resistance and heart rate by blocking both alpha-1 and beta-adrenergic receptors.
• Administration: Typically administered intravenously (IV), allowing for rapid onset of action.
• Dosage: The dosage is tailored to the individual patient's needs and response, often starting with a low dose and adjusting as necessary.
• Side Effects: May include dizziness, fatigue, headache, and gastrointestinal disturbances. Monitoring for potential adverse effects is essential.
• Contraindications: Not suitable for patients with certain conditions, such as asthma, severe bradycardia, or heart block.